Tranche Update on Bide Pharmatech Co., Ltd.'s Equity Buyback Plan announced on December 9, 2023.

Bide Pharmatech Co Ltd is a China-based company mainly engaged in pharmaceutical research and development. The Company's main businesses are the research, development, design, production and sales of drug molecular building blocks. The Company's main products are pharmaceutical molecular building blocks and scientific reagents. The Company's products are mainly used in drug target discovery, seed compound screening, lead compound discovery, synthesis and optimization. The Company conducts business in Asia Pacific, India, Europe, the United States and other regions.